Investigating the success rate of Microwave Ablation under the ultrasound guide in the treatment of Benign Thyroid Nodule

Abstract

Abstract Background One of the common reasons for patients to visit the clinic for endocrine diseases is thyroid disorders, especially benign thyroid nodules. Different pharmacological and nonpharmacological strategies are used to treat benign thyroid nodules. This study was conducted to determine the success rate of ultrasound-guided microwave ablation (MWA) in the treatment of benign thyroid nodules. Methods In this descriptive/cross-sectional study, the number of 22 patients with benign thyroid nodules who were treated with MWA from 2017 to 2020 was examined 6 and 12 months after treatment in terms of nodule volume changes and side effects. The data were analyzed with SPSS. Results The average age of patients is 35.45 years. 90.9% were female and 9.1% were male. The average volume of benign thyroid nodules in the patients under study was 15.37 ± 8.67 before treatment, 8.25 ± 6.52 in the sixth month of treatment, and 5.12 ± 6.65 in the twelfth month of treatment (P < 0.001). Among the side effects of MWA, pain was reported by 1 person, pressure symptoms were reported by 1 person, and scarring occurred by 2 people. Conclusions MWA is an effective, successful, and relatively safe procedure for the treatment of benign thyroid nodules.